PAH-specific therapy for pulmonary hypertension and interstitial lung disease: A systemic review and meta-analysis

OBJECTIVE: Pulmonary hypertension (PH) in context with interstitial lung disease (ILD) portends serious clinical consequences and a high rate of mortality. Recently published randomized controlled trials (RCTs) which assessed the pulmonary arterial hypertension (PAH)-specific drugs for pulmonary hyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Ning, Chen, Jun, Zhang, Mingming, Zhou, Lihui, Liu, Lisong, Yuan, Jie, Pang, Xingxue, Hu, Dayi, Ren, Xiaoxia, Jin, Zhongyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713234/
https://www.ncbi.nlm.nih.gov/pubmed/36465444
http://dx.doi.org/10.3389/fcvm.2022.992879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713234/
https://www.ncbi.nlm.nih.gov/pubmed/36465444
http://dx.doi.org/10.3389/fcvm.2022.992879

Ejemplares similares